Drug Profile


Alternative Names: Allegro; Auradol; EN 3266; Frova; Frovatriptan succinate; Isimig; Migard; Pitunal; Rilamig; SB 209509; SB 209509AX; VML 251

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer Endo Pharmaceuticals; Menarini; SK Chemicals; Teva Neuroscience; Vernalis
  • Class Antimigraines; Carbazoles; Small molecules; Tryptamines
  • Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Migraine
  • Preregistration Submission Withdrawal Menstrual migraine

Most Recent Events

  • 12 May 2016 First Generic equivalent available in USA for Migraine (PO)
  • 06 Aug 2011 Registered for Migraine in Russia (PO)
  • 08 Mar 2010 Vernalis terminates agreement with Paul Capital Healthcare
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top